Stock Report

Download full stock data and analysis for free Last Updated: 29-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

LeMaitre Vascular (LMAT) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$79.48

up-down-arrow $-0.19 (-0.24%)

As on 28-Aug-2026 13:37EDT

Market cap

info icon

$1,872 Mln

Revenue (TTM)

info icon

$262 Mln

P/E Ratio

info icon

28.6

P/B Ratio

info icon

4.5

Div. Yield

info icon

1.1 %

Edit peer-selector-edit
LeMaitre Vascular (LMAT) Penumbra (PEN) Glaukos Corp (GKOS) Repligen (RGEN) Bio-Rad Laboratories
Market cap ($ Mln)
 1,872 12,753 10,906 10,222 9,762
Revenue ($ Mln)
 262 1,505 613 785 2,589
Net Profit ($ Mln)
 65.67 160.59 -188.05 41.54 222.40
Net Margin (%)
 25.02 10.67 -30.68 5.29 8.59
RoE (%)
 16.14 10.86 -28.10 1.97 3.04
Price to Earnings
 28.62 79.35 -- 251.57 44.47
Price-To-Book
 4.46 8.41 16.38 4.84 1.26

Income Statement ($ Mln)

LeMaitre Vascular (LMAT) Penumbra (PEN) Glaukos Corp (GKOS) Repligen (RGEN) Bio-Rad Laboratories
Operating Revenue arrow
262.43 1,504.87 612.84 785.10 2,589.30
Cost of Revenue arrow
71.13 483.98 127.96 384.30 1,245.50
Gross Profit arrow
178.54 942.44 393.22 347.62 1,343.60
Operating Expenses arrow
113.99 833.56 565.37 335.50 1,108.90
Operating Profit (EBIT) arrow
77.32 187.34 -80.49 65.30 235.00
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
84.73 203.83 -192.83 52.15 350.40
Provision for Tax arrow
19.06 43.24 -4.79 10.61 128.00
Profit after Tax (Net Income) arrow
65.67 160.59 -188.05 41.54 222.40
Minority Interest arrow
0.00 0.00 0.00 0.00 0.00
Consolidated Profit arrow
0.00 93.19 0.00 0.00 0.00

Liabilities ($ Mln)

LeMaitre Vascular (LMAT) Penumbra (PEN) Glaukos Corp (GKOS) Repligen (RGEN) Bio-Rad Laboratories
Shareholder's Funds arrow
420.34 1,530.77 682.49 2,112.03 7,173.90
Minority Interest arrow
0.00 0.00 0.00 0.00 0.00
Non-Current Liabilities arrow
190.27 210.18 135.71 705.49 2,116.80
Current Liabilities arrow
29.94 233.78 102.33 132.66 961.30
Total Liabilities arrow
615.69 1,826.52 893.49 2,949.70 10,576.50

Assets ($ Mln)

LeMaitre Vascular (LMAT) Penumbra (PEN) Glaukos Corp (GKOS) Repligen (RGEN) Bio-Rad Laboratories
Non-Current Assets arrow
152.25 630.60 404.74 1,749.63 7,231.50
Current Assets arrow
488.30 1,344.12 515.78 1,200.55 3,020.50
Total Assets arrow
615.69 1,826.52 893.49 2,949.70 10,576.50
Total Debt* arrow
190.25 212.71 102.84 690.94 1,203.70
Net Current Assets arrow
458.36 1,110.35 413.45 1,067.90 2,059.20

Cashflow ($ Mln)

LeMaitre Vascular (LMAT) Penumbra (PEN) Glaukos Corp (GKOS) Repligen (RGEN) Bio-Rad Laboratories
Cash From Operating Activities arrow
81.25 238.66 -46.34 117.42 532.20
Cash Flow from Investing Activities arrow
-64.94 -404.59 -77.61 -298.47 -189.70
Cash from Financing Activities arrow
-14.54 26.53 11.89 -15.21 -283.20
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 LeMaitre Vascular (LMAT) Penumbra (PEN) Glaukos Corp (GKOS) Repligen (RGEN) Bio-Rad Laboratories
ROCE (%) arrow
10.48 11.76 -22.53 1.79 8.98
ROE (%) arrow
16.14 10.86 -28.10 1.97 3.04
ROA (%) arrow
10.27 7.95 -18.00 1.36 2.02
EBIT Margin (%) arrow
31.91 13.63 -30.58 9.87 -5.99
Net Margin (%) arrow
25.02 10.67 -30.68 5.29 8.59
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 LeMaitre Vascular (LMAT) Penumbra (PEN) Glaukos Corp (GKOS) Repligen (RGEN) Bio-Rad Laboratories
Revenue Growth (%) arrow
11.85 17.55 41.55 16.49 1.37
EBIT Growth (%) arrow
24.76 17.49 -116.42 920.91 -131.06
Net Profit Growth (%) arrow
39.39 8.72 -102.66 400.42 -30.32
EPS Growth (%) arrow
34.34 8.12 -96.88 394.30 -29.66
Book Value Growth (%) arrow
8.15 17.33 -12.65 2.16 2.19

Valuation Ratios

 LeMaitre Vascular (LMAT) Penumbra (PEN) Glaukos Corp (GKOS) Repligen (RGEN) Bio-Rad Laboratories
Price / Earnings arrow
32.26 68.93 -34.59 189.42 --
Price / Book Value arrow
4.73 8.58 9.90 4.40 --
Dividend Yield (%) arrow
-- -- -- -- --
EV/EBITDA arrow
18.61 53.25 -43.50 55.90 --
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 LeMaitre Vascular (LMAT) Penumbra (PEN) Glaukos Corp (GKOS) Repligen (RGEN) Bio-Rad Laboratories
Debt to Equity arrow
0.40 0.00 0.00 0.26 0.11
Short term debt to equity ratio arrow
0.01 0.01 0.00 0.01 0.06
Current Ratio arrow
16.31 5.75 5.04 9.05 3.14
Quick Ratio arrow
13.96 3.86 4.46 7.64 2.33
Interest Coverage arrow
17.30 157.91 -38.31 3.36 8.18

Operating Efficiency Ratios

 LeMaitre Vascular (LMAT) Penumbra (PEN) Glaukos Corp (GKOS) Repligen (RGEN) Bio-Rad Laboratories
Debtors to sales (%) arrow
13.60 12.65 22.67 20.09 17.06
Asset Turnover arrow
0.41 0.74 0.59 0.26 0.24
Receivable days arrow
46.59 46.54 60.95 72.41 65.39
Inventory Days arrow
324.74 331.92 193.84 146.53 221.09
Payable days arrow
13.90 26.16 60.19 29.05 37.02
Cash Conversion Cycle arrow
357.44 352.30 194.60 189.88 249.46
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...